Detalhe da pesquisa
1.
Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.
Emerg Infect Dis
; 30(3): 510-518, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407142
2.
A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.
Clin Infect Dis
; 73(7): e2465-e2469, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894278
3.
Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial.
Trop Med Int Health
; 23(9): 936-942, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29924907
4.
Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial.
Clin Infect Dis
; 64(1): 67-71, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803094
5.
Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.
J Infect Dis
; 211(2): 274-82, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25139016
6.
Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B.
Clin Infect Dis
; 61(6): 945-9, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26048961
7.
Pentavalent Antimony Associated with G-CSF in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis.
Pathogens
; 13(4)2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668256
8.
Improved Treatment Outcome Following the Use of a Wound Dressings in Cutaneous Leishmaniasis Lesions.
Pathogens
; 13(5)2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38787268
9.
Case report: Cyclophosphamide pulse therapy for chronic recalcitrant erythema nodosum leprosum.
Front Med (Lausanne)
; 10: 1272404, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020095
10.
Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis.
Open Forum Infect Dis
; 10(8): ofad387, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37564745
11.
Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study.
PLoS Negl Trop Dis
; 17(1): e0011029, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689465
12.
Miltefosine and cutaneous leishmaniasis.
Curr Opin Infect Dis
; 25(2): 141-4, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22248979
13.
A pilot and open trial to evaluate topical Bacterial Cellulose bio-curatives in the treatment of cutaneous leishmaniasis caused by L. braziliensis.
Acta Trop
; 225: 106192, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662548
14.
Clinical criteria for Mucosal Leishmaniasis diagnosis in rural South America: A systematic literature review.
PLoS Negl Trop Dis
; 16(8): e0010621, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947553
15.
The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis.
Front Cell Infect Microbiol
; 11: 740278, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34568099
16.
Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome.
An Bras Dermatol
; 96(5): 544-550, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330599
17.
High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis.
Front Cell Infect Microbiol
; 11: 652956, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33898330
18.
Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.
Int J Infect Dis
; 106: 83-90, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33578011
19.
Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial.
Int J Infect Dis
; 103: 358-363, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253864
20.
Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis.
Open Forum Infect Dis
; 7(12): ofaa491, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33324720